Article

New Products & Services

Raritan, NJ-The FDA has approved a once-a-day liquid formulation of the fluoroquinone antibiotic levofloxacin (Levaquin), from Ortho-McNeil Pharmaceutical, Inc. Levofloxacin is indicated for the treatment of a number of infections, including complicated and uncomplicated urinary tract infections, chronic bacterial prostatitis, and acute pyelonephritis.

Related Videos
Raymond Xu, MD, answers a question during a Zoom video interview
Timothy D. Lyon, MD, answers a question during a video interview
Modern medical office interior with computer and examination table | Image Credit: © New Africa - stock.adobe.com
Amy M. Pearlman, MD, interviews Gia Ching on Zoom
Related Content
© 2025 MJH Life Sciences

All rights reserved.